Indrayani Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 10.22 | 8.85 | 10.40 |
| Operating Expense | 7.56 | 6.86 | 8.07 |
| Net Profit | 1.11 | 0.11 | 0.10 |
| Net Profit Margin | 10.86 | 1.24 | 0.96 |
| Earning Per Share | 0.25 | 0.02 | 0.02 |
| EBIDTA | 3.45 | 1.99 | 2.34 |
| Effective Tax Rate | -4.14 | 2.01 | 1.29 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 10.22 |
| Operating Expense | 7.56 |
| Net Profit | 1.11 |
| Net Profit Margin | 10.86 |
| Earning Per Share | 0.25 |
| EBIDTA | 3.45 |
| Effective Tax Rate | -4.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 62.32 | 74.48 | 57.99 |
| Operating Expenses Annual | 56.66 | 65.83 | 51.76 |
| Operating Profit Annual | 9.28 | 8.80 | 6.45 |
| Interest Annual | 4.83 | 2.78 | 1.88 |
| Depreciation | 1.45 | 0.93 | 0.34 |
| Net Profit Annual | 1.46 | 5.06 | 4.23 |
| Tax Annual | 1.55 | 0.02 | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 62.32 |
| Operating Expenses Annual | 56.66 |
| Operating Profit Annual | 9.28 |
| Interest Annual | 4.83 |
| Depreciation | 1.45 |
| Net Profit Annual | 1.46 |
| Tax Annual | 1.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.62 | 1.45 | 0.63 |
| Cash Flow from Operations | 26.09 | 8.33 | 3.47 |
| Cash Flow from Investing | -7.26 | -14.09 | 0.59 |
| Cash Flow from Financing | -19.19 | 4.93 | -3.23 |
| Cash Flow at the End | 0.26 | 0.62 | 1.45 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.62 |
| Cash Flow from Operations | 26.09 |
| Cash Flow from Investing | -7.26 |
| Cash Flow from Financing | -19.19 |
| Cash Flow at the End | 0.26 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.12 | 11.90 | 11.14 |
| PBIT Margin (%) | 12.79 | 10.65 | 10.55 |
| PBT Margin (%) | 10.21 | 6.92 | 4.96 |
| Net PROFIT Margin (%) | 2.34 | 6.79 | 7.29 |
| Return On Networth / Equity (%) | 2.78 | 12.48 | 15.61 |
| Return On Networth /Employed (%) | 7.23 | 10.59 | 14.18 |
| Return On Assets (%) | 1.38 | 7.54 | 11.09 |
| Total Debt / Equity (X) | 1 | 0.79 | 0.73 |
| Asset Turnover Ratio (%) | 0.59 | 1.11 | 1.52 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.12 |
| PBIT Margin (%) | 12.79 |
| PBT Margin (%) | 10.21 |
| Net PROFIT Margin (%) | 2.34 |
| Return On Networth / Equity (%) | 2.78 |
| Return On Networth /Employed (%) | 7.23 |
| Return On Assets (%) | 1.38 |
| Total Debt / Equity (X) | 1 |
| Asset Turnover Ratio (%) | 0.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 21.66 | 23.81 | 15.33 |
| Total Current Assets Annual | 71.50 | 49.33 | 17.99 |
| Non Current Assets Annual | 54.50 | 50.97 | 31.44 |
| Total Shareholders Funds Annual | 54.52 | 51.15 | 24.18 |
| Total Assets Annual | 126.01 | 100.30 | 49.43 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 21.66 |
| Total Current Assets Annual | 71.50 |
| Non Current Assets Annual | 54.50 |
| Total Shareholders Funds Annual | 54.52 |
| Total Assets Annual | 126.01 |
EPS (INR)
Expected
0.00
Reported
-1.42
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
